Dr. Matthew George Cholankeril, MD

Dr. Cholankeril practices at Cholankeril Medical Associates MD in Elizabeth, New Jersey.

Dr. Cholankeril's NPI, 1003204850, was assigned on January 2, 2015. Dr. Cholankeril holds New Jersey license 25MA10018100.

Dr. Cholankeril's primary practice is Cholankeril Medical Associates MD, at 101 Grove St, Elizabeth, NJ 07202 in Union County. The practice phone is (908) 352-1738.

Dr. Cholankeril's primary practice is Cholankeril Medical Associates MD in Elizabeth, New Jersey. Dr. Cholankeril is also affiliated with Trinitas Regional Medical Center. The medical group on file is Cholankeril Medical Associates. Dmand AI also links Dr. Cholankeril to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cholankeril practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Cholankeril's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Cholankeril is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Cholankeril is licensed in New Jersey.

CMS data shows 5,803 Medicare services from Dr. Cholankeril across 40 procedure codes in 2024, for 551 Medicare patients. Medicare paid $539,877 for them.

CMS counts 551 Medicare patients who saw Dr. Cholankeril in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cholankeril's median patient age at 65, with 51% women.

In 2024, Dr. Cholankeril wrote 3,004 Medicare Part D claims for 429 patients. 85% of them were for generic drugs. CMS names the drug for 2,552 of them, across 59 drugs with 11 or more claims each, at $303,864 in total drug cost. In 2023, CMS named 2,213 claims across 57 drugs.

Dr. Cholankeril accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cholankeril as offering telehealth. CMS counts 22 procedures of varicose vein removal by Dr. Cholankeril, more than 59% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Cholankeril, published from 2012 to 2016. Dr. Cholankeril's most frequent co-authors are Jayanth Nmi Koneru, MD, Fayez Shamoon, MD and Marc Adelman, MD.

CMS Open Payments shows 104 general payments to Dr. Cholankeril from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Boston Scientific Corporation paid the most, $1,383.